2012 annual financial data
TG Therapeutics 2012 Financial results
Direct answer
Revenue was 19,048 USD.
Operating income was -26,895,099 USD and net income was -18,072,719 USD.
Operating cash flow was -5,187,964 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,048 USD
- Operating income
- -26,895,099 USD
- Net income
- -18,072,719 USD
- Operating cash flow
- -5,187,964 USD
Explore related company data
View all 2012 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all TG Therapeutics financial years